EDGAR Filing Documents for 0001171843-17-001427

Form 424B2 - Prospectus [Rule 424(b)(2)]:

SEC Accession No. 0001171843-17-001427

Filing Date

2017-03-10

Accepted

2017-03-10 17:05:14

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 424B2	f424b2_031017.htm	424B2	625962
2	GRAPHIC	logo.jpg	GRAPHIC	3856
3	GRAPHIC	logo2.jpg	GRAPHIC	2986
	Complete submission text file	0001171843-17-001427.txt		636658

Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703

Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302

BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)